Inhibition of IL-1β by canakinumab may be effective against diverse molecular subtypes of lung cancer: an exploratory analysis of the CANTOS trial
Wong, Connie C, Baum, Jason, Silvestro, Angela, Beste, Michael T, Bharani-Dharan, Bharani, Xu, Siyan, Wang, Ying A, Wang, Xiaoshan, Prescott, Margaret F, Krajkovich, Lynne, Dugan, Margaret, Ridker, PaJournal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-19-3176
Date:
October, 2020
File:
PDF, 564 KB
2020